Transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end of 2025
Nuvation Bio Inc., a late-stage,...
Reverba, renowned for its innovative patient engagement solutions for biopharmaceutical companies, announced the acquisition of Six Degrees Worldwide Inc., a leader in medical communications...
MOMA Therapeutics, a biopharmaceutical company discovering and developing a new generation of precision therapeutics via insights derived from the company’s KnowledgeBase platform, announced that...
MBrace Therapeutics, a clinical-stage biopharmaceutical company devoted to improving the lives of patients with cancer by developing novel antibody-drug conjugates (ADCs), announced the appointment...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN),...
